ArticleTranslational vision science & technology2026
Air-Coupled Ultrasonic Optical Coherence Elastography Reveals Protocol-Dependent Corneal Stiffening in Epi-On and Epi-Off Riboflavin Crosslinking.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Purpose: To evaluate the biomechanical impact of corneal crosslinking (CXL) when combining three different ultraviolet A (UV-A) riboflavin (RB) photosensitizers and protocols (Dresden protocol [DP] and accelerated protocol [AP]) using air-coupled ultrasonic optical coherence elastography in ex vivo rabbit corneas. Methods: An air-coupled ultrasound excitation optical coherence elastography system was used to excite the corneal apex and generate Lamb wave propagation along 16 corneal cross-sectional meridians. Measurements were conducted on ex vivo rabbit eyes (n = 45) during three treatment phases: Virgin, after 30 minutes of RB soaking, and after UV-A irradiation. The protocols used include the DP (3 mW/cm2, 30 minutes) and two accelerated protocols (AP-1: 9 mW/cm2, 10 minutes; and AP-2: 30 mW/cm2, 3 minutes). Each protocol was tested with three photosensitizers: epithelium-on (TE), and epithelium-off with hyperosmolar (M) and hypo-osmolar solutions (D). Lamb wave speed and average corneal thickness were calculated for each meridian to estimate meridian-dependent corneal shear modulus. Differences were statistically analyzed using linear mixed-effects regression. Results: The DP-D produced the strongest significant corneal stiffness increase (480.5 kPa; P < 0.001) during the UV irradiation phase, and the most pronounced corneal thinning (186 µm; P < 0.001). DP-TE achieved the next strongest stiffening (309.5 kPa) during UV irradiation, with no significant thickness change. All other protocol-photosensitizer combinations did not achieve significant corneal stiffening except for AP-1-D and AP-2-D during the RB soaking phase. Conclusions: Accelerated protocols did not produce significant corneal stiffening for any RB photosensitizer except when using dextran-based D. DP-D and DP-TE produced the greatest balance between shear modulus increase and corneal thickness decrease, suggesting DP-TE as a potential compromise between biomechanical impact, corneal integrity, and faster postoperative recovery. Translational Relevance: This work quantified the impact of clinically used crosslinking photosensitizers and protocols on corneal stiffening using an air-coupled ultrasound excitation optical coherence elastography, which holds promise for clinical assessments in patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.